BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36617900)

  • 1. [Cryptic COL1A1-PDGFB fusion in dermatofibrosarcoma protuberans: a clinicopathological and genetic analysis].
    Chen M; Chen YM; Lu Y; He X; Peng H; Zhang HY
    Zhonghua Bing Li Xue Za Zhi; 2023 Jan; 52(1):13-18. PubMed ID: 36617900
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of COL1A1-PDGFB breakpoints by next-generation sequencing in the molecular diagnosis of dermatofibrosarcoma protuberans.
    Zhu R; Yan J; Li B; Tan F; Yan W; Shen J; Fan L; Ding L; Chen Y; Tang Y; Liu Y; Bai Y
    Exp Mol Pathol; 2021 Oct; 122():104672. PubMed ID: 34371012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Characterization of Dermatofibrosarcoma Protuberans: The Clinicopathologic Significance of Uncommon Fusion Gene Rearrangements and Their Diagnostic Importance in the Exclusively Subcutaneous and Circumscribed Lesions.
    Lee PH; Huang SC; Wu PS; Tai HC; Lee CH; Lee JC; Kao YC; Tsai JW; Hsieh TH; Li CF; Li WS; Liu TT; Su YL; Yu SC; Huang HY
    Am J Surg Pathol; 2022 Jul; 46(7):942-955. PubMed ID: 35034038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of COL1A1-PDGFB fusion gene detection by fluorescence in situ hybridization in biopsy tissue of dermatofibrosarcoma protuberans.
    Zhang Z; Chen H; Chen M; He X; Wang Y; Zhang H
    J Dermatol; 2017 Jul; 44(7):798-802. PubMed ID: 28150334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays.
    Patel KU; Szabo SS; Hernandez VS; Prieto VG; Abruzzo LV; Lazar AJ; López-Terrada D
    Hum Pathol; 2008 Feb; 39(2):184-93. PubMed ID: 17950782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermatofibrosarcoma protuberans: a study of clinical, pathologic, genetic, and therapeutic features in Korean patients.
    Zheng Z; Piao J; Lee JH; Kim SE; Kim SC; Chung KY; Roh MR
    Yonsei Med J; 2015 Mar; 56(2):440-6. PubMed ID: 25683993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coamplification of 12q15 and 12p13 and homozygous CDKN2A/2B deletion: synergistic role of fibrosarcomatous transformation in dermatofibrosarcoma protuberans with a cryptic COL1A1-PDGFB fusion.
    Lu Y; Li T; Chen M; Peng H; Du T; Qiu Y; Zhang H
    Virchows Arch; 2022 Aug; 481(2):313-319. PubMed ID: 35171326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions.
    Dadone-Montaudié B; Alberti L; Duc A; Delespaul L; Lesluyes T; Pérot G; Lançon A; Paindavoine S; Di Mauro I; Blay JY; de la Fouchardière A; Chibon F; Karanian M; MacGrogan G; Kubiniek V; Keslair F; Cardot-Leccia N; Michot A; Perrin V; Zekri Y; Coindre JM; Tirode F; Pedeutour F; Ranchère-Vince D; Le Loarer F; Pissaloux D
    Mod Pathol; 2018 Nov; 31(11):1683-1693. PubMed ID: 29955147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plaque-like CD34-positive dermal fibroma ("medallion-like dermal dendrocyte hamartoma"): clinicopathologic, immunohistochemical, and molecular analysis of 5 cases emphasizing its distinction from superficial, plaque-like dermatofibrosarcoma protuberans.
    Kutzner H; Mentzel T; Palmedo G; Hantschke M; Rütten A; Paredes BE; Schärer L; Guillen CS; Requena L
    Am J Surg Pathol; 2010 Feb; 34(2):190-201. PubMed ID: 20061935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular diagnosis of dermatofibrosarcoma protuberans: a comparison between reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization methodologies.
    Salgado R; Llombart B; M Pujol R; Fernández-Serra A; Sanmartín O; Toll A; Rubio L; Segura S; Barranco C; Serra-Guillén C; Yébenes M; Salido M; Traves V; Monteagudo C; Sáez E; Hernández T; de Álava E; Llombart-Bosch A; Solé F; Guillén C; Espinet B; López-Guerrero JA
    Genes Chromosomes Cancer; 2011 Jul; 50(7):510-7. PubMed ID: 21484928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDGFB rearrangement in dermatofibrosarcoma protuberans: correlation with clinicopathologic characteristics and clinical implications.
    Ha SY; Lee SE; Kwon MJ; Kim YJ; Lee EH; Seo J; Jang KT; Lee J; Choi YL
    Hum Pathol; 2013 Jul; 44(7):1300-9. PubMed ID: 23347652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatofibrosarcoma protuberans of the vulva and groin: detection of COL1A1-PDGFB fusion transcripts by RT-PCR.
    Gökden N; Dehner LP; Zhu X; Pfeifer JD
    J Cutan Pathol; 2003 Mar; 30(3):190-5. PubMed ID: 12641779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic gains of COL1A1-PDFGB occur in the histologic evolution of giant cell fibroblastoma into dermatofibrosarcoma protuberans.
    Macarenco RS; Zamolyi R; Franco MF; Nascimento AG; Abott JJ; Wang X; Erickson-Johnson MR; Oliveira AM
    Genes Chromosomes Cancer; 2008 Mar; 47(3):260-5. PubMed ID: 18069662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of COL1A1-PDGFB fusion transcripts in dermatofibrosarcoma protuberans by reverse transcription-polymerase chain reaction using archival formalin-fixed, paraffin-embedded tissues.
    Wang J; Hisaoka M; Shimajiri S; Morimitsu Y; Hashimoto H
    Diagn Mol Pathol; 1999 Sep; 8(3):113-9. PubMed ID: 10565681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and clinicopathological analysis of dermatofibrosarcoma protuberans.
    Walluks K; Chen Y; Woelfel C; Yang L; Cui T; Seliger C; Geier C; Knösel T; Hauke S; Petersen I
    Pathol Res Pract; 2013 Jan; 209(1):30-5. PubMed ID: 23207290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.
    Llombart B; Monteagudo C; Sanmartín O; López-Guerrero JA; Serra-Guillén C; Poveda A; Jorda E; Fernandez-Serra A; Pellín A; Guillén C; Llombart-Bosch A
    J Am Acad Dermatol; 2011 Sep; 65(3):564-575. PubMed ID: 21570152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatofibrosarcoma protuberans with COL1A1 (exon 18) -PDGFB (exon 2) fusion transcript.
    Saeki H; Ohmatsu H; Hoashi T; Asano N; Idezuki T; Kawabata Y; Asahina A; Kikuchi K; Tamaki K
    Br J Dermatol; 2003 May; 148(5):1028-31. PubMed ID: 12786837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [From cytogenetics to cytogenomics of dermatofibrosarcoma protuberans family of tumors].
    Bianchini L; Maire G; Pedeutour F;
    Bull Cancer; 2007 Feb; 94(2):179-89. PubMed ID: 17337387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of dermatofibrosarcoma protuberans of the vulva with a COL1A1/PDGFB fusion identical to a case of giant cell fibroblastoma.
    Vanni R; Faa G; Dettori T; Melis GB; Dumanski JP; O'Brien KP
    Virchows Arch; 2000 Jul; 437(1):95-100. PubMed ID: 10963386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel fusion gene of collagen type I alpha 1 (exon 31) and platelet-derived growth factor B-chain (exon 2) in dermatofibrosarcoma protuberans.
    Nakanishi G; Lin SN; Asagoe K; Suzuki N; Matsuo A; Tanaka R; Makino E; Fujimoto W; Iwatsuki K
    Eur J Dermatol; 2007; 17(3):217-9. PubMed ID: 17478383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.